Latest filing published 26 Sept 2023 for Reata Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Andrea Loewen: trading record in brief
This profile gathers the share dealings of Andrea Loewen in Reata Pharmaceuticals Inc. The record holds 11 filings, for trades running from 3 January 2023 to 26 September 2023.
On the market, this insider has only sold: 8 sales, €2.7M in total. Other entries cover 1 share grant and 1 option exercise.
On 26 September 2023 came the latest disclosure, a transaction in Reata Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrea Loewen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,416 sharesClass A common stockSEC:0000899243-23-019541:0
- 3,175 shares@ US$172.025435.4% of flowClass A common stockSEC:0001209191-23-049792:0
- 6,750 shares@ US$86.261836.8% of flowClass A common stockSEC:0001209191-23-029791:0
- 15,000 shares@ US$27.3226.5% of flowClass A common stockSEC:0001209191-23-017553:0
- 218 shares@ US$90.611.3% of flowClass A common stockSEC:0001209191-23-016327:0
- 11,756 shares0Class A common stockSEC:0001209191-23-001018:0
6 of 6 declarations
